Genetic Engineering and CRISPR/Cas 9 Technology

Genetic engineering is revolutionizing the biotech industry and is increasingly applied in previously unthought-of markets. Recently, a lot of commercial and near-commercial cases have been seen within industrial biotechnology, where genetic engineering principles and tools are applied in microbe-based products. Genetic engineering has significantly expanded the range of chemical products which can now be synthesized biologically.

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assembly of the next generation of bioproducts. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, biochemicals, agricultural crops, and travel applications.

  • Locus Structure and Mechanism
  • Genome Editing Methods and Novel Tools
  • CRISPR Technologies and Society
  • Synthetic DNA
  • Advanced synthetic biology tools
  • High value- low volume products
  • Synthetic biotechnology
  • Achieving Efficient Delivery and Editing
  • Horizons of CRISPR Biology

Related Conference of Genetic Engineering and CRISPR/Cas 9 Technology

Genetic Engineering and CRISPR/Cas 9 Technology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in